Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prehabilitation for Advanced Ovarian Cancer Patients

NCT05047926 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05047926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05047926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prehabilitation for Advanced Ovarian Cancer Patients
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2021
Completion date
July 8, 2025
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced ovarian carcinoma, stage iiic fallopian tube cancer ajcc v8, stage iiic ovarian cancer ajcc v8, stage iiic primary peritoneal cancer ajcc v8, stage iv fallopian tube cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv primary peritoneal cancer ajcc v8